MicroRNAS and their significance in the population of dialysis patients
- Authors: Rind A.R.1, Yesayan A.M1, Kayukov I.G.1, Zaraysky M.I1
-
Affiliations:
- I.P. Pavlov First St. Petersburg State Medical University
- Issue: Vol 12, No 4 (2020)
- Pages: 65-69
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273360
- DOI: https://doi.org/10.18565/nephrology.2020.4.65-69
- ID: 273360
Cite item
Abstract
Full Text
About the authors
A. R. Rind
I.P. Pavlov First St. Petersburg State Medical University
Email: anastasiia.rind@gmail.com
Postgraduate Student at the Department of Nephrology and Dialysis, FPGE St. Petersburg, Russia
A. M Yesayan
I.P. Pavlov First St. Petersburg State Medical University
Email: essaian.ashot@gmail.com
Dr. Sci. (Med.), Professor, Head of the Department of Nephrology and Dialysis, FPGE St. Petersburg, Russia
I. G. Kayukov
I.P. Pavlov First St. Petersburg State Medical UniversityDr. Sci. (Med.), Professor at the Department of Nephrology and Dialysis, , FPGE St. Petersburg, Russia
M. I Zaraysky
I.P. Pavlov First St. Petersburg State Medical University
Email: mzaraiski@yandex.ru
Dr. Sci. (Med.), Professor at the Department of Clinical Laboratory Diagnostics St. Petersburg, Russia
References
- Abdellatif M. Differential Expression of MicroRNAs in Different Disease States. Circ Res. 2015; 110:638-650.
- Cipollone F, Felicioni L, Sarzani R., et al. A unique microRNA signature associated with plaque instability in humans. Stroke. 2018; 42:2556-2563. microRNA expression and classical risk factors in the risk of coronary heart disease. Scientific Reports. 2015; 5:14925.
- Gacon J., Badacz R., Stqpien E., et al. Diagnostic and prognostic micro -RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study. Kardiol Pol. 2018;76(2):362-369. doi: 10.5603/KP.a2017.0243.
- Szeto C.C., Wang G, Ng J.KC. et al. Urinary miRNA profile for the diagnosis of IgA nephropathy. BMC Nephrol 2019;20. https://doi.org/10.1186/ s12882-019-1267-4
- Liu Z, Wang S, Mi Q.S., Dong Z. MicroRNAs in pathogenesis of acute kidney injury. Nephron. 2016;134:149-153. doi: 10.1159/000446551.
- Hamdorf M., Kawakita S., Everly M. The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection. J Immunol Res. 2017;2017:4072364. doi: 10.1155/2017/4072364.
- Khan Z, Suthanthiran M., Muthukumar T. MicroRNAs and Transplantation. Clin Lab Med. 2019Mar;39(1):125-143. doi: 10.1016/j.cll.2018.10.003.
- Lopez-Anton M., Bowen T., Jenkins R.H. microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis. Biomed Res Int. 2015;2015:929806. doi: 10.1155/2015/929806.
- Chen C.L., Lin C.H., Li A.L., Huang C.C., Shen B.Y., Chiang Y.R., Fang P.L., Chang H.C., Li K.L., Yang W.C., Horng J.T., Ma N. Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients. Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1094-F1102. doi: 10.1152/ajprenal.00014.2019.
- Wu C.C., Chen L.J., Hsieh M.Y., Lo C.M., Lin M.H., Tsai H.E., Song H.L., Chiu J.J. MicroRNA-21 and Venous Neointimal Hyperplasia of Dialysis Vascular Access. Clin J Am Soc Nephrol. 2018;13(11): 1712-1720. doi: 10.2215/CJN.02410218.
- Ketszeri M., Kir sc h A., Frauscher B., Moschovaki-Filippidou F., Mooslechner A.A., Kirsch A.H., Schabhuettl C., Aringer I., Artinger K., Pregartner G., Ekart R., Breznik S., Hojs R., Goessler W., Schilcher I., Mtiller H., Obermayer-Pietsch B., Frank S., Rosenkranz A.R., Eller P., Eller K. MicroRNA-142-3p improvesvascularrelaxation in uremia. Atherosclerosis. 2019;280:28-36. doi: 10.1016/j.atherosclerosis.2018.11.024.
- Szeto C.C., Chow K.M., Kwan B.C., Cheng P.M., Luk C.C., Ng J.K., Law M.C., Leung C.B., Li P.K. Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. Clin Chim Acta. 2017;464:106-112. doi: 10.1016/j.cca.2016.11.020.
- Lopez-Anton M., Lambie M., Lopez-Cabrera M., Schmitt C.P., Ruiz-Carpio V., Bartosova M., Schaefer B., Davies S., Stone T., Jenkins R., Taylor P.R., Topley N., Bowen T., Fraser D. miR-21 Promotes Fibrogenesis in Peritoneal Dialysis. Am J Pathol. 2017;187(7):1537-1550. doi: 10.1016/j.ajpath.2017.03.007.
- Dziedzic M., Orlowska E., Powrozek T., Solski J. Role of circulating microRNA in hemodialyzedpatients. Postepy Hig Med Dosw (Online). 2016;70(0):1362-1366. doi: 10.5604/17322693.1227641. PMID: 28234233.
- Cavallari C., Dellepiane S., Fonsato V., Medica D., Marengo M., Migliori M., Quercia A.D., Pitino A., Formica M., Panichi V., Maffei S., Biancone L., Gatti E., Tetta C., Camussi G., Cantaluppi V. Online Hemodiafiltration Inhibits Inflammation-Related Endothelial Dysfunction and Vascular Calcification of Uremic Patients Modulating miR-223 Expression in Plasma Extracellular Vesicles. J Immunol. 2019;202(8):2372-2383. Doi: 10.4049/ jimmunol.1800747.
- El Sharkawy M., Aly O., Elsayed H., Ezzat H., Mohab A, Usama D. MicroRNA 499 gene expression in patients on hemodialysis with cardiovascular complications. Hemodial Int. 2017 Oct;21 Suppl 2:S16-S21. Doi: 10.1111/ hdi.12594. Erratum in: Hemodial Int. 2018;22(1):140.
- Mellis D., Caporali A. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2018;46(1):11-21. doi: 10.1042/BST20170037.
- Vegter E.L., van der Meer P., de Windt L.J., Pinto Y.M., Voors A.A. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18(5):457-468. doi: 10.1002/ejhf.495.
- Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2017;107(6):810-817. Doi: 10.1161/ CIRCRESAHA.110.226357.
- Nattel S. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation. JACC Clin Electrophysiol. 2017;3(5):425-435. Doi: 10.1016/j. jacep.2017.03.002.
- Komal S., Yin J.J., Wang S.H., Huang C.Z., Tao H.L., Dong J.Z., Han S.N., Zhang L.R. MicroRNAs: Emerging biomarkers for atrial fibrillation. J Cardiol. 2019;74(6):475-482. doi: 10.1016/j.jjcc.2019.05.018.
- Aryal B., Singh A.K., Rotllan N., Price N., Fernandez-Hernando C. MicroRNAs and lipid metabolism. Curr Opin Lipidol. 2017;28(3):273-280. doi: 10.1097/MOL.0000000000000420.